Clinical Trial Update: Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions [Phase 3]

View source ↗

Summary

Phase 3 trial update on zoledronic acid in metastatic breast cancer patients with non-symptomatic bone lesions; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer, Neoplasm Metastasis | Phase 3 | Status: TERMINATED